Main glossary


Browse the glossary using this index

Special | A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | ALL

Page: (Previous)   1  2  3  (Next)
  ALL

C

Compound rescue

Compound rescue is taking a potential drug compound at advanced stage of pharma development but abandoned before drug approval, and testing it a disease that is different than the one it was originally developed for and then abandoned.


Consent

Providing permission for something to happen or agreement to do something


Contract research organisation

Any organisation that provides services relating to clinical research, such as the development of medicines, clinical trials and commercialisation


Control group

A control group in a clinical trial is given either an existing standard treatment or a placebo, to serve as a base line for the new medicine's effects to be tested against.


Corporate Social Responsibility

Corporate Social Responsibility (CSR) is the voluntary activities undertaken by a company to operate in an economic, social, and environmentally sustainable manner.


Cost of illness

A measure of the economic burden of a disease on society, incorporating all costs of the disease.



Cost-consequence model

A model that details the costs and outcomes of an intervention separately, without combining the two elements


Cost-effectiveness

A measure of the value a new treatment provides by looking at the costs per unit of benefit.


Cost-effectiveness

A measure of the value a new treatment provides by looking at the costs per unit of benefit.



Cost-effectiveness model

A model that compares the costs and benefits of two or more interventions




Page: (Previous)   1  2  3  (Next)
  ALL